342 related articles for article (PubMed ID: 21385870)
1. Role of YKL-40 in the angiogenesis, radioresistance, and progression of glioblastoma.
Francescone RA; Scully S; Faibish M; Taylor SL; Oh D; Moral L; Yan W; Bentley B; Shao R
J Biol Chem; 2011 Apr; 286(17):15332-43. PubMed ID: 21385870
[TBL] [Abstract][Full Text] [Related]
2. YKL-40, a secreted glycoprotein, promotes tumor angiogenesis.
Shao R; Hamel K; Petersen L; Cao QJ; Arenas RB; Bigelow C; Bentley B; Yan W
Oncogene; 2009 Dec; 28(50):4456-68. PubMed ID: 19767768
[TBL] [Abstract][Full Text] [Related]
3. A YKL-40-neutralizing antibody blocks tumor angiogenesis and progression: a potential therapeutic agent in cancers.
Faibish M; Francescone R; Bentley B; Yan W; Shao R
Mol Cancer Ther; 2011 May; 10(5):742-51. PubMed ID: 21357475
[TBL] [Abstract][Full Text] [Related]
4. Chitinase 3-like protein 2 (CHI3L2, YKL-39) activates phosphorylation of extracellular signal-regulated kinases ERK1/ERK2 in human embryonic kidney (HEK293) and human glioblastoma (U87 MG) cells.
Areshkov PA; Kavsan VM
Tsitol Genet; 2010; 44(1):3-9. PubMed ID: 20201406
[TBL] [Abstract][Full Text] [Related]
5. Experimental anti-angiogenesis causes upregulation of genes associated with poor survival in glioblastoma.
Saidi A; Javerzat S; Bellahcène A; De Vos J; Bello L; Castronovo V; Deprez M; Loiseau H; Bikfalvi A; Hagedorn M
Int J Cancer; 2008 May; 122(10):2187-98. PubMed ID: 18092325
[TBL] [Abstract][Full Text] [Related]
6. Anti-YKL-40 antibody and ionizing irradiation synergistically inhibit tumor vascularization and malignancy in glioblastoma.
Shao R; Francescone R; Ngernyuang N; Bentley B; Taylor SL; Moral L; Yan W
Carcinogenesis; 2014 Feb; 35(2):373-82. PubMed ID: 24282289
[TBL] [Abstract][Full Text] [Related]
7. Regulation of YKL-40 expression during genotoxic or microenvironmental stress in human glioblastoma cells.
Junker N; Johansen JS; Hansen LT; Lund EL; Kristjansen PE
Cancer Sci; 2005 Mar; 96(3):183-90. PubMed ID: 15771622
[TBL] [Abstract][Full Text] [Related]
8. Constitutive NF-kappaB activity regulates the expression of VEGF and IL-8 and tumor angiogenesis of human glioblastoma.
Xie TX; Xia Z; Zhang N; Gong W; Huang S
Oncol Rep; 2010 Mar; 23(3):725-32. PubMed ID: 20127012
[TBL] [Abstract][Full Text] [Related]
9. Knockdown of YKL-40 inhibits angiogenesis through regulation of VEGF/VEGFR2 and ERK1/2 signaling in endometrial cancer.
Chen HY; Zhou ZY; Luo YL; Luo Q; Fan JT
Cell Biol Int; 2021 Dec; 45(12):2557-2566. PubMed ID: 34498339
[TBL] [Abstract][Full Text] [Related]
10. Tumor-derived mural-like cells coordinate with endothelial cells: role of YKL-40 in mural cell-mediated angiogenesis.
Francescone R; Ngernyuang N; Yan W; Bentley B; Shao R
Oncogene; 2014 Apr; 33(16):2110-22. PubMed ID: 23665676
[TBL] [Abstract][Full Text] [Related]
11. TrkB-containing exosomes promote the transfer of glioblastoma aggressiveness to YKL-40-inactivated glioblastoma cells.
Pinet S; Bessette B; Vedrenne N; Lacroix A; Richard L; Jauberteau MO; Battu S; Lalloué F
Oncotarget; 2016 Aug; 7(31):50349-50364. PubMed ID: 27385098
[TBL] [Abstract][Full Text] [Related]
12. YKL-40 expression is associated with poorer response to radiation and shorter overall survival in glioblastoma.
Pelloski CE; Mahajan A; Maor M; Chang EL; Woo S; Gilbert M; Colman H; Yang H; Ledoux A; Blair H; Passe S; Jenkins RB; Aldape KD
Clin Cancer Res; 2005 May; 11(9):3326-34. PubMed ID: 15867231
[TBL] [Abstract][Full Text] [Related]
13. YKL-40 downregulation is a key factor to overcome temozolomide resistance in a glioblastoma cell line.
Akiyama Y; Ashizawa T; Komiyama M; Miyata H; Oshita C; Omiya M; Iizuka A; Kume A; Sugino T; Hayashi N; Mitsuya K; Nakasu Y; Yamaguchi K
Oncol Rep; 2014 Jul; 32(1):159-66. PubMed ID: 24842123
[TBL] [Abstract][Full Text] [Related]
14. The vascular delta-like ligand-4 (DLL4)-Notch4 signaling correlates with angiogenesis in primary glioblastoma: an immunohistochemical study.
Zhang JF; Chen Y; Qiu XX; Tang WL; Zhang JD; Huang JH; Lin GS; Wang XF; Lin ZX
Tumour Biol; 2016 Mar; 37(3):3797-805. PubMed ID: 26472724
[TBL] [Abstract][Full Text] [Related]
15. DNA-PKcs deficiency inhibits glioblastoma cell-derived angiogenesis after ionizing radiation.
Liu Y; Zhang L; Liu Y; Sun C; Zhang H; Miao G; Di CX; Zhou X; Zhou R; Wang Z
J Cell Physiol; 2015 May; 230(5):1094-103. PubMed ID: 25294801
[TBL] [Abstract][Full Text] [Related]
16. Association between YKL-40 and adult primary astrocytoma.
Zhang W; Kawanishi M; Miyake K; Kagawa M; Kawai N; Murao K; Nishiyama A; Fei Z; Zhang X; Tamiya T
Cancer; 2010 Jun; 116(11):2688-97. PubMed ID: 20499402
[TBL] [Abstract][Full Text] [Related]
17. Resveratrol represses YKL-40 expression in human glioma U87 cells.
Zhang W; Murao K; Zhang X; Matsumoto K; Diah S; Okada M; Miyake K; Kawai N; Fei Z; Tamiya T
BMC Cancer; 2010 Oct; 10():593. PubMed ID: 21029458
[TBL] [Abstract][Full Text] [Related]
18. YKL-40 is directly produced by tumor cells and is inversely linked to EGFR in glioblastomas.
Horbinski C; Wang G; Wiley CA
Int J Clin Exp Pathol; 2010 Jan; 3(3):226-37. PubMed ID: 20224722
[TBL] [Abstract][Full Text] [Related]
19. Is YKL-40 a new therapeutic target in cancer?
Johansen JS; Jensen BV; Roslind A; Price PA
Expert Opin Ther Targets; 2007 Feb; 11(2):219-34. PubMed ID: 17227236
[TBL] [Abstract][Full Text] [Related]
20. Blockage of the vascular endothelial growth factor stress response increases the antitumor effects of ionizing radiation.
Gorski DH; Beckett MA; Jaskowiak NT; Calvin DP; Mauceri HJ; Salloum RM; Seetharam S; Koons A; Hari DM; Kufe DW; Weichselbaum RR
Cancer Res; 1999 Jul; 59(14):3374-8. PubMed ID: 10416597
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
